Advertisement

Ads Placeholder
Loading...

TAO Synergies Inc.

TAOX•NASDAQ
Healthcare
Biotechnology
$5.20
$-0.32(-5.80%)
U.S. Market is Open • 11:49

TAO Synergies Inc. (TAOX) Stock Overview

Explore TAO Synergies Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17.1M
P/E Ratio-0.33
EPS (TTM)$-8.81
ROE-1.83%
Fundamental Analysis

AI Price Forecasts

1 Month$14.50
3 Months$5.00
1 Year Target$1.00

TAOX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TAO Synergies Inc. (TAOX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.33 and a market capitalization of 17.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.80%
5-Day Change
-7.64%
1-Month Change
30.98%
3-Month Change
-2.62%
6-Month Change
-32.03%
Year-to-Date (YTD) Change
17.38%
1-Year Change
30.00%
3-Year Change
30.00%
5-Year Change
30.00%
All-Time (Max) Change
30.00%

Contact Information

https://www.synaptogen.com
NaN
1185 Avenue of the Americas, 3rd Floor, New York, NaN, 10036

Company Facts

40 Employees
IPO DateJul 2, 2025
CountryUS
Actively Trading

Frequently Asked Questions